乾皮症治療の世界市場レポート 2025年

乾皮症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.4％で116億9,000万米ドルに成長します。予測期間中に予測される成長は、人口の高齢化、環境汚染の増加、スキンケア習慣の改善への注目の高まり、皮膚関連の健康懸念の増加、個人向けスキンケア製品の採用拡大などの要因によるものと考えられます。予測期間に予想される主な動向には、局所治療の発展、保湿剤の処方技術の改善、処方箋ベースのスキンケアソリューションの革新、新しい治療法の臨床試験の進展、ウェアラブルスキンケア機器の開発などがあります。

乾皮症治療市場の成長予測は、ヘルスケア支出の増加に大きく起因しています。ヘルスケア支出とは、個人、政府、組織が予防、診断、治療、疾病管理などのヘルスケアサービスに割り当てる総資源を指します。医療技術の進歩に伴い、新しい診断ツールや治療には高い開発費、導入費、継続治療費がかかることが多いため、ヘルスケアコストは増加しています。このような支出の増加は、皮膚科医療へのアクセスを向上させ、専門家によるサポートや高度な治療オプションを通じて、乾皮症の早期診断と継続的な管理を促進します。例えば、2024年5月、英国国家統計局は、2023年の総ヘルスケア支出は5.6％増加し、2022年の長期医療・社会保障支出は実質ベースで2.8％増加したと報告しました。その結果、ヘルスケア支出の増加が乾皮症治療市場の拡大を牽引しています。

乾皮症治療市場の主要企業は、皮膚のバリア機能を向上させ、乾燥肌の状態をよりよく管理するために、より長時間の保湿を提供するソフトローションなどの革新的なソリューションの開発に注力しています。ソフトローションは、肌にやさしく潤いを与えるように設計された、軽くてべたつかない保湿剤で、敏感肌や普通肌の日常使いに最適です。例えば、2022年2月、インドの製薬会社カディラ・ファーマシューティカルズは、様々な乾燥性皮膚疾患の治療用に処方されたラグロー・ソフトローションを発売しました。このローションは、乾皮症、魚鱗癬、アトピー性皮膚炎、乾癬などの疾患に効果的です。また、皮膚の老化にも効果があり、副腎皮質ステロイドと併用することもできます。この処方は、深い保湿を提供し、皮膚全体の健康を高めることを目的としています。その効果が実証されているラグロー・ソフトローションは、スキンケアのための包括的なソリューションを提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界乾皮症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の乾皮症治療市場：成長率分析
• 世界の乾皮症治療市場の実績：規模と成長, 2019-2024
• 世界の乾皮症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界乾皮症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の乾皮症治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬
• パーソナルケア製品
• 世界の乾皮症治療市場：形態別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• ローション
• クリーム
• 軟膏
• シャワーフォーム
• その他の形式
• 世界の乾皮症治療市場症状別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 粗さ
• 締め付け感
• かゆみ
• かさついた皮膚
• 世界の乾皮症治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 在宅ケア設定
• その他エンドユーザー
• 世界の乾皮症治療市場、医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所コルチコステロイド
• 経口抗ヒスタミン薬
• 免疫調節薬
• 抗菌剤
• 抗真菌剤
• 世界の乾皮症治療市場パーソナルケア製品のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 保湿剤
• エモリエント剤
• 保湿剤
• 入浴剤
• クレンザー

第7章 地域別・国別分析

• 世界の乾皮症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の乾皮症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 乾皮症治療市場：競合情勢
• 乾皮症治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • The Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Unilever PLC Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi S.A.
• L'Oreal S.A.
• GlaxoSmithKline plc
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Ltd.
• Galderma S.A.
• Dr. Reddy's Laboratories Ltd.
• LEO Pharma A/S
• Arcutis Biotherapeutics Inc.
• Neutrogena
• Aveeno
• CeraVe
• La Roche-Posay
• Nivea
• Cetaphil

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 乾皮症治療市場2029：新たな機会を提供する国
• 乾皮症治療市場2029：新たな機会を提供するセグメント
• 乾皮症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Xerosis treatment aims to restore moisture to the skin and repair the skin barrier to alleviate dryness, flaking, and discomfort. This typically involves the use of emollients and moisturizers to hydrate the skin and prevent further water loss. Additionally, gentle skin care practices, such as using mild, fragrance-free cleansers and avoiding hot water or aggressive scrubbing, are essential.

The primary treatments for xerosis include medications and personal care products. Medications are substances or compounds used to diagnose, treat, prevent, or manage medical conditions. These are available in various forms, including tablets, lotions, creams, ointments, and shower products. Medications help address symptoms such as roughness, tightness, itching, and flaky skin, and are used in settings including hospitals, clinics, and home care environments.

The xerosis treatment market research report is one of a series of new reports from The Business Research Company that provides xerosis treatment market statistics, including xerosis treatment global market size, regional shares, competitors with a xerosis treatment market share, xerosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the xerosis treatment. This xerosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The xerosis treatment market size has grown strongly in recent years. It will grow from $8.96 billion in 2024 to $9.47 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth observed during the historical period can be attributed to several factors, including the increasing prevalence of dry skin conditions, growing awareness about skin health, a rise in dermatological consultations, greater availability of over-the-counter moisturizers, and a growing demand for natural and organic skincare products.

The xerosis treatment market size is expected to see strong growth in the next few years. It will grow to $11.69 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth projected during the forecast period can be attributed to factors such as an aging population, rising environmental pollution, an increased focus on improving skincare routines, a rise in skin-related health concerns, and a growing adoption of personalized skincare products. Key trends expected in the forecast period include advancements in topical treatments, improved formulation technologies for moisturizers, innovation in prescription-based skincare solutions, progress in clinical trials for new therapies, and the development of wearable skincare devices.

The projected growth of the xerosis treatment market is largely attributed to the rising healthcare expenditure. Healthcare expenditure refers to the total resources allocated to health services, including prevention, diagnosis, treatment, and disease management, by individuals, governments, and organizations. With advancements in medical technology, healthcare costs are increasing as newer diagnostic tools and treatments often involve higher development, implementation, and ongoing care costs. This increased spending enhances access to dermatological care, facilitating early diagnosis and ongoing management of xerosis through professional support and advanced treatment options. For example, in May 2024, the UK's Office for National Statistics reported that total healthcare spending grew by 5.6% in 2023, while long-term health and social care expenditure rose by 2.8% in real terms in 2022. As a result, the growing healthcare expenditure is driving the expansion of the xerosis treatment market.

Leading companies in the xerosis treatment market are focusing on developing innovative solutions, such as soft lotions, to improve skin barrier function and provide longer-lasting hydration for better management of dry skin conditions. Soft lotion is a lightweight, non-greasy moisturizing formula designed to gently hydrate the skin, making it ideal for daily use on sensitive or normal skin types. For example, in February 2022, Cadila Pharmaceuticals, a pharmaceutical company based in India, introduced Laglo Soft Lotion, formulated to treat a range of dry skin conditions. This lotion is effective in managing disorders such as xerosis, ichthyosis, atopic dermatitis, and psoriasis. It also helps with skin aging and can be used alongside corticosteroids as a co-therapy. The formula aims to offer deep hydration and enhance overall skin health. With its proven effectiveness, Laglo Soft Lotion provides a comprehensive solution for skincare.

In January 2022, Galderma, a Switzerland-based pharmaceutical company, acquired ALASTIN Skincare Inc. for an undisclosed amount. This acquisition was intended to enhance Galderma's dermatology portfolio by incorporating ALASTIN's innovative, physician-recommended skincare products, which complement Galderma's existing offerings. The move also aimed to accelerate ALASTIN's growth by leveraging Galderma's global reach and resources to expand its presence with healthcare professionals and consumers. ALASTIN Skincare Inc. is a US-based company, offering a range of products focused on treating and managing xerosis (dry skin), with an emphasis on hydration, barrier repair, and overall skin health.

Major players in the xerosis treatment market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Unilever PLC, Bayer AG, Sanofi S.A., L'Oreal S.A., GlaxoSmithKline plc, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Galderma S.A., Dr. Reddy's Laboratories Ltd., LEO Pharma A/S, Arcutis Biotherapeutics Inc., Neutrogena, Aveeno, CeraVe, La Roche-Posay, Nivea, and Cetaphil.

North America was the largest region in the xerosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in xerosis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the xerosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The xerosis treatment market consists of sales of cleansing bars, body oils and barrier repair creams. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Xerosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on xerosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for xerosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The xerosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Medication; Personal Care Products
• 2) By Form: Tablets; Lotion; Cream; Ointment; Shower Forms; Other Forms
• 3) By Symptoms: Roughness; Tightness; Itching; Flaky Skin
• 4) By End Users: Hospitals; Clinics; Homecare Settings; Other End Users
• Subsegments:
• 1) By Medication: Topical Corticosteroids; Oral Antihistamines; Immunomodulators; Antibacterial Agents; Antifungal Agents
• 2) By Personal Care Products: Moisturizers; Emollients; Humectants; Bath Additives; Cleansers
• Companies Mentioned: Pfizer Inc.; The Procter & Gamble Company; Johnson & Johnson; Unilever PLC; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Xerosis Treatment Market Characteristics

3. Xerosis Treatment Market Trends And Strategies

4. Xerosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Xerosis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Xerosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Xerosis Treatment Market Growth Rate Analysis
• 5.4. Global Xerosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Xerosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Xerosis Treatment Total Addressable Market (TAM)

6. Xerosis Treatment Market Segmentation

• 6.1. Global Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Personal Care Products
• 6.2. Global Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Lotion
• Cream
• Ointment
• Shower Forms
• Other Forms
• 6.3. Global Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Roughness
• Tightness
• Itching
• Flaky Skin
• 6.4. Global Xerosis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare Settings
• Others End Users
• 6.5. Global Xerosis Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Corticosteroids
• Oral Antihistamines
• Immunomodulators
• Antibacterial Agents
• Antifungal Agents
• 6.6. Global Xerosis Treatment Market, Sub-Segmentation Of Personal Care Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Moisturizers
• Emollients
• Humectants
• Bath Additives
• Cleansers

7. Xerosis Treatment Market Regional And Country Analysis

• 7.1. Global Xerosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Xerosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Xerosis Treatment Market

• 8.1. Asia-Pacific Xerosis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Xerosis Treatment Market

• 9.1. China Xerosis Treatment Market Overview
• 9.2. China Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Xerosis Treatment Market

• 10.1. India Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Xerosis Treatment Market

• 11.1. Japan Xerosis Treatment Market Overview
• 11.2. Japan Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Xerosis Treatment Market

• 12.1. Australia Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Xerosis Treatment Market

• 13.1. Indonesia Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Xerosis Treatment Market

• 14.1. South Korea Xerosis Treatment Market Overview
• 14.2. South Korea Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Xerosis Treatment Market

• 15.1. Western Europe Xerosis Treatment Market Overview
• 15.2. Western Europe Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Xerosis Treatment Market

• 16.1. UK Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Xerosis Treatment Market

• 17.1. Germany Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Xerosis Treatment Market

• 18.1. France Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Xerosis Treatment Market

• 19.1. Italy Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Xerosis Treatment Market

• 20.1. Spain Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Xerosis Treatment Market

• 21.1. Eastern Europe Xerosis Treatment Market Overview
• 21.2. Eastern Europe Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Xerosis Treatment Market

• 22.1. Russia Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Xerosis Treatment Market

• 23.1. North America Xerosis Treatment Market Overview
• 23.2. North America Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Xerosis Treatment Market

• 24.1. USA Xerosis Treatment Market Overview
• 24.2. USA Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Xerosis Treatment Market

• 25.1. Canada Xerosis Treatment Market Overview
• 25.2. Canada Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Xerosis Treatment Market

• 26.1. South America Xerosis Treatment Market Overview
• 26.2. South America Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Xerosis Treatment Market

• 27.1. Brazil Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Xerosis Treatment Market

• 28.1. Middle East Xerosis Treatment Market Overview
• 28.2. Middle East Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Xerosis Treatment Market

• 29.1. Africa Xerosis Treatment Market Overview
• 29.2. Africa Xerosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Xerosis Treatment Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Xerosis Treatment Market, Segmentation By Symptoms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Xerosis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Xerosis Treatment Market Competitive Landscape
• 30.2. Xerosis Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. The Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Unilever PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Xerosis Treatment Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. L'Oreal S.A.
• 31.3. GlaxoSmithKline plc
• 31.4. Bausch Health Companies Inc.
• 31.5. Sun Pharmaceutical Industries Ltd.
• 31.6. Galderma S.A.
• 31.7. Dr. Reddy's Laboratories Ltd.
• 31.8. LEO Pharma A/S
• 31.9. Arcutis Biotherapeutics Inc.
• 31.10. Neutrogena
• 31.11. Aveeno
• 31.12. CeraVe
• 31.13. La Roche-Posay
• 31.14. Nivea
• 31.15. Cetaphil

32. Global Xerosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Xerosis Treatment Market

34. Recent Developments In The Xerosis Treatment Market

35. Xerosis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Xerosis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Xerosis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Xerosis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer